Haeseong Park Selected Research

Haeseong Park Research Topics

Disease

27	Neoplasms (Cancer) 12/2023 - 06/2015
9	Adenocarcinoma 10/2023 - 12/2017
8	Breast Neoplasms (Breast Cancer) 11/2023 - 06/2011
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2020
3	Disease Progression 01/2023 - 01/2019
3	Rectal Neoplasms (Rectal Cancer) 01/2021 - 12/2017
3	Sickle Cell Anemia (Hemoglobin S Disease) 10/2009 - 03/2008
2	Pancreatic Neoplasms (Pancreatic Cancer) 12/2023 - 11/2020
2	Fatigue 01/2022 - 01/2021
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2022
2	Exanthema (Rash) 01/2022 - 01/2022
2	Hodgkin Disease (Hodgkin's Disease) 11/2020 - 01/2019
2	Stomach Neoplasms (Stomach Cancer) 01/2020 - 01/2019
2	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2020 - 10/2017
2	Hot Flashes 06/2015 - 06/2011
2	Heart Failure 04/2011 - 08/2009
1	Mitochondrial Diseases (Mitochondrial Disease) 12/2023
1	Bites and Stings (Sting) 12/2023
1	Overweight 11/2023
1	Neutropenia 11/2023
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2023
1	Neoplasm Metastasis (Metastasis) 01/2023
1	Esophageal Squamous Cell Carcinoma 01/2023
1	Disease Resistance 03/2022
1	Leukopenia 01/2022
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2022
1	Colitis 01/2022
1	Hemorrhage 01/2022
1	Hypokalemia 01/2022
1	Hyponatremia 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2022
1	Lymphopenia (Lymphocytopenia) 01/2022
1	Respiratory Insufficiency (Respiratory Failure) 01/2022
1	Abdominal Pain (Pain, Abdominal) 01/2022
1	Squamous Cell Neoplasms (Squamous Cell Cancer) 01/2022
1	Microsatellite Instability 01/2022
1	Hyperglycemia 07/2021
1	Anemia 07/2021
1	Adenocarcinoma of Lung 07/2021
1	Edema (Dropsy) 07/2021

Drug/Important Bio-Agent (IBA)

6	pembrolizumabIBA 10/2023 - 01/2020
6	Trastuzumab (Herceptin)FDA Link 01/2023 - 01/2019
5	trastuzumab deruxtecanIBA 01/2023 - 01/2019
4	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2019
4	Biomarkers (Surrogate Marker)IBA 01/2023 - 08/2009
3	B7-H1 AntigenIBA 01/2023 - 01/2019
3	NivolumabIBA 01/2023 - 01/2022
3	Hydroxyurea (Hydrea)FDA LinkGeneric 10/2009 - 03/2008
2	Leucovorin (Folinic Acid)FDA Link 12/2023 - 01/2020
2	Gemcitabine FDA Link 12/2023 - 01/2023
2	InterferonsIBA 12/2023 - 01/2020
2	Fluorouracil (Carac)FDA LinkGeneric 12/2023 - 01/2020
2	Irinotecan (Camptosar)FDA LinkGeneric 12/2023 - 01/2020
2	Hormones (Hormone)IBA 11/2023 - 09/2019
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 10/2023 - 01/2020
2	IronIBA 01/2023 - 10/2009
2	Circulating Tumor DNAIBA 01/2023 - 01/2021
2	Immunoconjugates (Immunoconjugate)IBA 01/2023 - 01/2020
2	margetuximabIBA 01/2023 - 01/2020
2	Monoclonal AntibodiesIBA 11/2022 - 01/2020
2	Everolimus FDA Link 07/2021 - 11/2020
2	COVID-19 VaccinesIBA 05/2021 - 01/2021
2	Vorinostat FDA Link 11/2020 - 10/2016
2	Histone Deacetylase InhibitorsIBA 11/2020 - 10/2016
2	Sirolimus (Rapamycin)FDA Link 11/2020 - 10/2016
2	Magnesium Oxide (Magnesia)FDA Link 06/2015 - 06/2011
2	MagnesiumIBA 06/2015 - 06/2011
2	CreatinineIBA 04/2011 - 08/2009
1	IntegrinsIBA 12/2023
1	Vitamin D FDA LinkGeneric 12/2023
1	paricalcitol (Zemplar)FDA Link 12/2023
1	palbociclibIBA 11/2023
1	Capecitabine (Xeloda)FDA Link 10/2023
1	Biocompatible Materials (Biomaterials)IBA 01/2023
1	Transferrin Receptors (Transferrin Receptor)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 01/2023
1	Deferoxamine (Desferal)FDA LinkGeneric 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Chelating AgentsIBA 01/2023
1	neratinibIBA 01/2023
1	IpilimumabIBA 01/2023
1	ulixertinibIBA 01/2023
1	130-nm albumin-bound paclitaxelIBA 01/2023
1	human ERBB2 proteinIBA 01/2023
1	Transferrin (beta 2 Transferrin)IBA 01/2023
1	Toll-Like Receptor 4IBA 11/2022
1	Plant Growth Regulators (Plant Hormones)IBA 03/2022
1	durvalumabIBA 01/2022
1	vorolanibIBA 01/2022
1	cyclopropapyrroloindoleIBA 01/2022
1	tremelimumabIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 01/2022
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022
1	Inducible T-Cell Co-Stimulator ProteinIBA 01/2022

Therapy/Procedure

22	Therapeutics 12/2023 - 10/2009
12	Drug Therapy (Chemotherapy) 12/2023 - 01/2019
4	Immunotherapy 01/2023 - 10/2017
3	Neoadjuvant Therapy 01/2023 - 01/2021
3	Radiotherapy 01/2022 - 01/2020